Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 222 participants.
Also called NCT01326026
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 222 participants
- Sponsor
- Registry
-
NCT01326026 -
2010-022337-29
-
- Other papers using this trial's data
- Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Finland, Germany, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01326026. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2015-11-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
- Acronym
- BEGIN™
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- insulin degludec
- Intervention (Drug)
- insulin degludec
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01326026- Content hash
cedb7a0222f1cb192ed5daa8c5c7a836735194f179ead9f01b86e07e37394f16